2. Impact of 3D Printing at the Supply Chain Level
The supply chain can be defined as “a set of entities (e.g., organizations or individuals) directly involved in the supply and distribution flows of goods, services, finances, and information from a source to a destination (customer)”
[15]. This process begins with the raw materials, continues with the creation of the product, which passes through the hands of the intermediaries (wholesalers and retailers), and ends with the supply of the final product to the customer. The introduction of additive manufacturing leads companies to adopt a new production paradigm and therefore, it is necessary to reformulate the supply chain capable of managing manufacturing activities
[16]. With the introduction of 3D printing into the production process, there are a series of changes in warehouse management, in the number of actors involved in the chain and in activities related to production volumes: in addition to determining the transition from a production of mass scale (based on standardized goods) to additive manufacturing, (based on the creation of customized products at lower costs), 3D printing offers a way to simplify the production chain by determining a less complex supply chain and significantly reducing it
[17]. For example, through additive manufacturing assembly is less necessary as there are products that can be printed in one piece; this implies less coordination of suppliers and a consequent reduction in costs and time. Otherwise, with traditional production methods it is necessary to produce each component separately and then assemble them together at a later time
[18]. The biggest change introduced by the 3D printer concerns the displacement of production in space, in fact, after having designed the model of a product, through the transfer of the file via a simple internet connection, it is possible to produce the object in question anywhere in the world: in this way the number of intermediaries is reduced with a consequent saving in transport costs and also the time to market is reduced
[16]. With reference to the medical field, this is precisely what happened during the first months of the COVID-19 pandemic: the technology allowed the transfer to thousands of computers of the 3D model of the design of a face mask and a component of the cooling fan. Rather than waiting for medical components to first be mass-produced abroad and then shipped to hospitals, 3D printing made it possible to manufacture them nearby and on demand
[19]. Additive manufacturing applied to the medical sector has also led to a reduction in the relocation of the supply chain since health facilities and hospitals, instead of sourcing from foreign companies, can produce medical equipment and components directly within the hospital itself
[20], giving a relevant improvement in aligning and streamline the entire health care supply chain from providers to purchasers
[21].
In addition to the creation of highly customized and on-demand products, additive manufacturing also leads to profound changes in the management of internal logistics and in the production of spare parts. This technology leads to a series of advantages in relation to the reduction of waste as it reduces the need to hold large quantities of products or spare parts in the warehouse; all this because 3D printing allows to obtain unique products in small series, making it possible to print the products at the right time and only on specific request. According to this logic, instead of keeping spare components in stock, companies could hold files that store the different geometries of the components to be created, creating a sort of “virtual warehouse”, significantly reducing logistics costs
[18].
From an environmental point of view, although plastic is the most used material
[22], companies using 3D printing are moving towards the use of more sustainable and environmentally friendly materials
[23]. With additive technology, the amount of waste is also drastically reduced as it makes it possible to produce layer by layer, as opposed to the subtractive technique which produces a significant amount of waste.
The introduction of 3D printing in production processes marks the transition from a production oriented to “build to stock” to one to “build to order”: in the first case it is a question of basing production on market studies and demand estimates, in the second production takes place on request, it is produced only if the consumer places an order, in this way the stocks of products are reduced to a minimum, waste is reduced and the risks of overproduction are avoided
[24].
3. 3D Printing Impacts at the Corporate Organization Level
When a 3D printer is introduced within the business organization, the main concern is raised by the fact that 3D printers, in all stages of production, do not require human intervention except in the initial configuration phase. In the event that the product produced is not a finished product, then it is possible that man can intervene in the assembly phase, but in the event that the printer reproduces a finished product it will perform its tasks in total autonomy. In any case, introducing a new machine into the processes does not mean that this necessarily replaces the work of man, but, with a change of perspective, it can be thought of as a complementary technology to man, which makes it easier and fast execution of complex activities.
The figure of the worker will always be present in the production cycle, in particular in the phases concerning the design, the implementation of 3D systems and in the management of the business, defining a form of flexible work organization and thus eliminating the old structural and technological constraints that often required a single choice between man and machine
[25].
In addition to this form of flexible organization, in the medical field, the use of the 3D printer has led to a reorganization of roles as well as the birth of new “hybrid” figures within the hospital system, since the use of 3D printing is certainly a revolution that changes the way of doing medicine and within the production processes leads to innovation also of a cultural nature
[26].
Within the health and hospital facilities, alongside surgical doctors and radiologists, there is the figure of the 3D specialist that is configured with the figure of the biomedical engineer who provides technical support in the design and production process and has led to major changes in the organizational system
[27]. If you think, for example, of the creation of a 3D printed prosthesis, the collaboration of engineers and doctors is necessary since the design and application requires a series of integrated knowledge of physics, medicine and cell biology
[28].
Considering the main criticalities of using Additive Manufacturing in the medical field, there is the difficulty in the identification of the most suitable 3D technology: for example, a supplier of healthcare products that decides to implement additive manufacturing in its processes must carefully select the most suitable technique in reference to its production chain and raw materials that allow an optimal reproduction of the object
[29].
Another criticality is related to the training of personnel who must be highly qualified in order to be able to juggle highly sophisticated technologies: this aspect involves the incurring of costs for training and continuous refresher courses as stated by Weidert et al.
[30].
From an ethical and social point of view, questions arise regarding the use of the press and the responsibilities of those involved in the event of malfunction of medical products. In the health sector, to date, there is still no specific legislation in the United States and Europe that regulates these products, which fall within the Research & Development activities; for a number of aspects, therefore, the 3D printing scenario is very fragmented especially in Europe, but it is expected that in the future a standardization of operations will be applied at an international level
[31].
4. Conclusions
The fields of application of 3D printing are numerous, but the sector in which more research is carried out and which appears to be constantly growing is certainly the one related to healthcare, allowing additive manufacturing to become a leading production technique in the medical sector for a wide range of applications. Working in this context requires a vision oriented to a digital, farsighted and innovative perspective which, within the context in which it operates, leads to innovation also in the organizational culture of healthcare facilities
[18]. Technologies adopted by companies in the medical field are different, and as shown in literature the most adopted technology is FDM.
As it concerns RQ1, the study shows that the general impact at the business organization level is quite significant, highlighting how the adoption of these technologies leads to a new organizational culture
[32][37]. The use of 3D printing changes the way of doing medicine, leading to profound changes within production and distribution processes
[26]. By transforming these concepts into concrete ideas, two fronts of innovation can be identified. The first refers to the possibility of creating customized solutions for bone and orthodontics prostheses and medical aids, increasing the number of possible applications and modifying production techniques. In this way, there is a tendency to overcome the traditional industrial setting, which starts from standard items and then makes possible adjustments, to achieve an opposite approach that starts with tailor-made solutions for the individual application.
The second front of innovation concerns the production of pharmaceuticals and the overlapping of production and distribution phases: 3D printing can represent a solution for the production of medicines directly in the pharmacy, also taking into account the fact that the composition of drugs tends to be tailored to the individual patient’s pathology.
Therefore, it emerges that the adoption of 3D printers within the medical sector can lead to a change in the shape of both production and distribution processes. It has been previously discussed how the additive manufacturing technique has made changes in the development of products, especially at the production of prototypes level
[33][38]. Current trends, as this
enst
rudy highlights, are showing a further stage of development of 3D printing, involving several phased of production and questioning the business models of the medical and pharmaceutical sectors so far established. Among the main consequences, there is the fact that the layer-to-layer production logic allows simplifying procedures and ensures reduced times
[16][19][16,19].
As for the impact at the supply chain level, starting from the assumption that the biggest change introduced by the 3D printer concerns the displacement of production in space (allowing the creation of an object anywhere), this means that the number of intermediaries in going to be significantly reduced, favoring faster production and, consequently, a reduced time to market. Furthermore, benefits can be seen also in the reduction of stocks in warehouses, as well as a reduction of waste related to overproduction of materials.
With regard to the attributes related to current and future opportunities and barriers generated by the adoption of the aforementioned technologies in the medical sector (RQ2), the research shows consensus in relation to the development of highly personalized materials aimed at improving the lives of individuals and the possibility of new market outlets. Undoubtably, the development of 3D printers can bring to a series of improvements in medical applications, contributing to preserve people’s health and save lives. The new frontiers concern the possibility of 3D printing human organs such as heart, liver and lungs and, through the innovative bioprinting technique, the possibility of producing ad hoc human organs and tissues using human cells, reducing the risk of rejection and obviating the problem of long waiting lists in transplant centers. This aspect leads back to another opportunity positively valued by companies, related to the development of biocompatible materials. It still remains a challenge to ensure that bioprinted tissues properly match the structure and properties of native tissues.
Among the opportunities that 3D printing in the healthcare sector is going though, the relevant impact of the technology during the current pandemic period cannot be overlooked. 3D printers had a relevant role, thanks to networks of makers who have organized themselves as new manufacturers, and to universities which exploited facilities and staff’s skills. There has been a great effort and collaboration to address the pandemic and the acute need for PPE and medical equipment that could not be fulfilled by existing manufacturing capacity, due to increased lead times, lack of government planning and procurement of these equipment.
As regards the criticalities and weaknesses related to the 3D printing use, they appear to be perceived by companies as very weak and not very significant. It has been observed that the most important attributes concern the adequate training of personnel and the unregulated market in which they operate.
As regards the non-regulation of the market, the main international standardization bodies including the International Organization for Standardization (ISO) and the American Society for Testing Materials (ASTM) are working assiduously for the creation of technical standards that can regulate the sector. Similar efforts are expected from the European Union and individual states to regulate these activities by means of directives and laws.